Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.004 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |